Clinical Trials Sponsored by Arisaph Pharmaceuticals Inc
Total 4988 results
-
Julie E. Bauman, MD, MPHAVEO Pharmaceuticals, Inc.TerminatedCarcinoma, Squamous Cell of Head and NeckUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Jina Pharmaceuticals Inc.CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of British ColumbiaBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompleted
-
Michael Moncure, MDPacira Pharmaceuticals, IncCompleted
-
University of South FloridaFriedreich's Ataxia Research Alliance; Edison Pharmaceuticals IncCompleted
-
Children's Center for Digestive Health CareTakeda Pharmaceuticals North America, Inc.CompletedAsthma | Gastroesophageal Reflux DiseaseUnited States
-
Duke UniversityNational Institutes of Health (NIH); Keryx / AOI Pharmaceuticals, Inc.CompletedGlioblastoma Multiforme | Anaplastic GliomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
University of North Carolina, Chapel HillTakeda Pharmaceuticals North America, Inc.CompletedIrritable Bowel SyndromeUnited States
-
Sun Yat-sen UniversityGeneCast Biotechnology Co., Ltd.; Allist Pharmaceuticals, Inc.RecruitingNon-small Cell Lung CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Progenics Pharmaceuticals, Inc.Active, not recruitingStudy of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate CancerProstate CancerUnited States
-
Venatorx Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
Kalyra Pharmaceuticals, Inc.United States Department of Defense; PRA Health SciencesTerminated
-
Diffusion Pharmaceuticals IncUniversity of California, Los Angeles; University of VirginiaTerminatedStroke, AcuteUnited States
-
Defense and Veterans Center for Integrative Pain...Pacira Pharmaceuticals, IncCompletedPain, PostoperativeUnited States
-
Charite University, Berlin, GermanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedImpact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS)Stroke | Atrial FibrillationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of California, DavisNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IIIA Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
University Hospital Center of MartiniquePfizer; Boston Pharmaceuticals; MicroPort Orthopedics Inc.Completed
-
Venatorx Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
St. Jude Children's Research HospitalOhio State University; Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer Network; AVEO Pharmaceuticals, Inc.TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); AMAG Pharmaceuticals, Inc.TerminatedBrain NeoplasmsUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
University of North Carolina, Chapel HillTakeda Pharmaceuticals North America, Inc.CompletedOverweight | Gastroesophageal Reflux Disease | Acid Reflux DiseaseUnited States
-
McNeil Consumer & Specialty Pharmaceuticals, a...AngeliniCompleted
-
University of KansasDUSA Pharmaceuticals, Inc.CompletedHidradenitis SuppurativaUnited States
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaboratorsRecruitingGlioblastomaUnited States, France, Germany, Canada, Australia, Switzerland
-
Research in Real-Life LtdNovartis PharmaceuticalsUnknown
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Belgium, Canada, Italy, United Kingdom, Hungary, Taiwan, Australia, Germany, Spain, Austria, Russian Federation, Korea, Republic of, China, France, Brazil, Ireland, Argentina, Romania, Poland
-
Research in Real-Life LtdMeda PharmaceuticalsCompleted
-
Sandra SwainGenentech, Inc.; Medstar Health Research Institute; Lombardi Comprehensive Cancer... and other collaboratorsCompletedDiarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients (HALT-D)Breast CancerUnited States
-
Ciusss de L'Est de l'Île de MontréalOtsuka Canada Pharmaceutical Inc.CompletedTreatment-resistant Schizophrenia | Auditory Hallucination, VerbalCanada
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
University of British ColumbiaTeva Branded Pharmaceutical Products R&D, Inc.Unknown
-
Livzon Pharmaceutical Group Inc.Fifth Affiliated Hospital, Sun Yat-Sen UniversityCompletedHelicobacter Pylori Eradication Antibiotic
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.TerminatedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
Rambam Health Care CampusTeva Branded Pharmaceutical Products R&D, Inc.CompletedAsthma | Bronchial HyperresponsivenessIsrael
-
Teva Branded Pharmaceutical Products R&D, Inc.H. Lundbeck A/SCompletedMultiple System AtrophyUnited States, Austria, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Spain, United Kingdom
-
Ruhr University of BochumTeva Branded Pharmaceutical Products R&D, Inc.WithdrawnAged | Chronic Renal Insufficiency | Accidental FallsGermany
-
University of ManitobaJanssen-Ortho Inc., Canada; PriCara, Unit of Ortho-McNeil, Inc.; Ortho-McNeil...TerminatedAcute Uncomplicated PyelonephritisCanada
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Novartis Pharmaceuticals; Rho Federal Systems Division, Inc.Active, not recruitingPeanut Allergy | Multi-food AllergyUnited States
-
University of ColognePfizer; F2G Biotech GmbH; Basilea Pharmaceutica; Cidara Therapeutics Inc.; Matinas...RecruitingInvasive Fungal DiseaseGermany